What is SpinTech MRI?
SpinTech MRI, based in Michigan, is a quantitative magnetic resonance imaging (MRI) platform dedicated to accelerating and enhancing the diagnosis and treatment of neurological conditions such as Parkinson's, Alzheimer's, and dementia. The company's innovative approach aims to provide clearer, more precise diagnostic insights, thereby improving patient outcomes and treatment strategies in a critical healthcare sector.
How much funding has SpinTech MRI raised?
SpinTech MRI has raised a total of $6.5M across 1 funding round:
Series A
$6.5M
Series A (2022): $6.5M with participation from Genesis Innovation Group’s Cultivate(MD) Capital Fund and Level8 Ventures
Key Investors in SpinTech MRI
Genesis Innovation Group’s Cultivate(MD) Capital Fund
Genesis Innovation Group’s Cultivate(MD) Capital Fund is an investment entity likely focused on medical device and healthcare innovations, providing crucial backing for SpinTech MRI's specialized platform.
Level8 Ventures
Level8 Ventures, operating within the Consumer Services industry, provides strategic investment and operational support, likely contributing to SpinTech MRI's market penetration and business development efforts.
Undisclosed Investor
An undisclosed investor participated in this funding round, indicating a strategic interest in SpinTech MRI's technology and market potential.
What's next for SpinTech MRI?
The substantial enterprise-level funding positions SpinTech MRI for significant scaling and further development of its quantitative MRI platform. This strategic capital infusion is expected to fuel research and development, expand clinical validation, and potentially broaden the company's market reach. The focus on neurological diseases, a rapidly growing area of medical concern, suggests a trajectory towards becoming a key player in diagnostic imaging technology.
See full SpinTech MRI company page
